Literature DB >> 23134217

Consumer involvement in topic and outcome selection in the development of clinical practice guidelines.

Allison Tong1, Pamela Lopez-Vargas, Martin Howell, Richard Phoon, David Johnson, Denise Campbell, Rowan G Walker, Jonathan C Craig.   

Abstract

BACKGROUND: Consumer involvement in guideline development is advocated, but minimal participation, such as a nominated consumer representative on a guideline working group, can inhibit their decision-making power and contribution. Little is known about how to involve consumers more effectively in guideline development.
OBJECTIVE: To describe a targeted approach for involving consumers actively in guideline development, by focusing on topic and outcome selection, and to discuss the impact on content and structure of the final guideline.
DESIGN: Descriptive study. SETTING AND PARTICIPANTS: Patients and carers (n = 24) from a tertiary hospital in Sydney attended three structured peer-facilitated workshops to complete group-based exercises on topic and outcome selection for guidelines for early stage chronic kidney disease. These workshops were run in parallel with the guideline-writing group. For each exercise, participants formed small groups and facilitated their own discussion, recorded their responses and presented them to the wider group. The topics and outcomes identified were fed back to the guideline writers.
RESULTS: The participants actively engaged in the workshop discussions and articulated topics and outcomes they perceived should be included in clinical guidelines. Four main changes to guideline-related outputs were observed. A new guideline subtopic was introduced, guidelines were consumer-endorsed, guideline recommendations and suggestions for clinical care were augmented with consumer-focused issues, and plain English guidelines were developed.
CONCLUSIONS: Consumer workshops in parallel and feeding into guideline development can be a feasible and effective approach for active consumer contribution. This process can inform the development of both consumer-focused guidelines for clinicians and specific versions for consumers.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 23134217      PMCID: PMC5060636          DOI: 10.1111/j.1369-7625.2011.00676.x

Source DB:  PubMed          Journal:  Health Expect        ISSN: 1369-6513            Impact factor:   3.377


  10 in total

1.  Relation between agendas of the research community and the research consumer.

Authors:  D Tallon; J Chard; P Dieppe
Journal:  Lancet       Date:  2000-06-10       Impact factor: 79.321

2.  The next step in guideline development: incorporating patient preferences.

Authors:  Murray Krahn; Gary Naglie
Journal:  JAMA       Date:  2008-07-23       Impact factor: 56.272

Review 3.  Lay perspectives: advantages for health research.

Authors:  V A Entwistle; M J Renfrew; S Yearley; J Forrester; T Lamont
Journal:  BMJ       Date:  1998-02-07

4.  Raising the standard: practice guidelines and consumer participation.

Authors:  H Bastian
Journal:  Int J Qual Health Care       Date:  1996-10       Impact factor: 2.038

5.  Involvement of consumers in the development of evidence based clinical guidelines: practical experiences from the North of England evidence based guideline development programme.

Authors:  A van Wersch; M Eccles
Journal:  Qual Health Care       Date:  2001-03

6.  Patient and public involvement in clinical guidelines: international experiences and future perspectives.

Authors:  Antoine Boivin; Kay Currie; Béatrice Fervers; Javier Gracia; Marian James; Catherine Marshall; Carol Sakala; Sylvia Sanger; Judi Strid; Victoria Thomas; Trudy van der Weijden; Richard Grol; Jako Burgers
Journal:  Qual Saf Health Care       Date:  2010-04-27

Review 7.  Methods of consumer involvement in developing healthcare policy and research, clinical practice guidelines and patient information material.

Authors:  E S Nilsen; H T Myrhaug; M Johansen; S Oliver; A D Oxman
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

8.  Patient choice and patient empowerment in northern European health systems: a conceptual framework.

Authors:  R B Saltman
Journal:  Int J Health Serv       Date:  1994       Impact factor: 1.663

9.  Why consider patients' preferences? A discourse analysis of clinical practice guideline developers.

Authors:  Antoine Boivin; Judith Green; Jan van der Meulen; France Légaré; Ellen Nolte
Journal:  Med Care       Date:  2009-08       Impact factor: 2.983

10.  Improving the use of research evidence in guideline development: 10. Integrating values and consumer involvement.

Authors:  Holger J Schünemann; Atle Fretheim; Andrew D Oxman
Journal:  Health Res Policy Syst       Date:  2006-12-05
  10 in total
  15 in total

1.  Editorial.

Authors:  Jonathan Tritter
Journal:  Health Expect       Date:  2012-12       Impact factor: 3.377

2.  Supporting a person-centred approach in clinical guidelines. A position paper of the Allied Health Community - Guidelines International Network (G-I-N).

Authors:  Simone A van Dulmen; Sue Lukersmith; Josephine Muxlow; Elaine Santa Mina; Maria W G Nijhuis-van der Sanden; Philip J van der Wees
Journal:  Health Expect       Date:  2013-10-14       Impact factor: 3.377

Review 3.  Practical Considerations for Using Online Methods to Engage Patients in Guideline Development.

Authors:  Sean Grant; Glen S Hazlewood; Holly L Peay; Ann Lucas; Ian Coulter; Arlene Fink; Dmitry Khodyakov
Journal:  Patient       Date:  2018-04       Impact factor: 3.883

Review 4.  Patient and Public Involvement in the Development of Healthcare Guidance: An Overview of Current Methods and Future Challenges.

Authors:  Ahmed Rashid; Victoria Thomas; Toni Shaw; Gillian Leng
Journal:  Patient       Date:  2017-06       Impact factor: 3.883

5.  Incorporating patient preferences in the management of multiple long-term conditions: is this a role for clinical practice guidelines?

Authors:  Charlotte E Young; Frances M Boyle; Katie S Brooker; Allyson J Mutch
Journal:  J Comorb       Date:  2015-11-11

6.  Impact of patient involvement on clinical practice guideline development: a parallel group study.

Authors:  Melissa J Armstrong; C Daniel Mullins; Gary S Gronseth; Anna R Gagliardi
Journal:  Implement Sci       Date:  2018-04-16       Impact factor: 7.327

7.  Setting Priorities for Optimizing Vascular Access Decision Making--An International Survey of Patients and Clinicians.

Authors:  Sabine N van der Veer; Maria C Haller; Carina A C M Pittens; Jacqueline Broerse; Clare Castledine; Maurizio Gallieni; Nicholas Inston; Anna Marti Monros; Niels Peek; Wim van Biesen
Journal:  PLoS One       Date:  2015-07-07       Impact factor: 3.240

8.  Patient involvement in guidelines is poor five years after institute of medicine standards: review of guideline methodologies.

Authors:  Melissa J Armstrong; Joshua A Bloom
Journal:  Res Involv Engagem       Date:  2017-10-02

9.  Framework for enhancing clinical practice guidelines through continuous patient engagement.

Authors:  Melissa J Armstrong; Juan-David Rueda; Gary S Gronseth; C Daniel Mullins
Journal:  Health Expect       Date:  2016-04-26       Impact factor: 3.377

Review 10.  Assessment of kidney transplant suitability for patients with prior cancers: is it time for a rethink?

Authors:  Wai H Lim; Eric Au; Anoushka Krishnan; Germaine Wong
Journal:  Transpl Int       Date:  2019-08-28       Impact factor: 3.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.